honokiol has been researched along with Lung Injury, Acute in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Li, W; Wang, D | 1 |
Kuo, CW; Liu, SH; Weng, TI; Wu, HY | 1 |
Chen, BL; Liu, SH; Weng, TI; Wu, HY | 1 |
3 other study(ies) available for honokiol and Lung Injury, Acute
Article | Year |
---|---|
[Honokiol attenuates lipopolysaccharide-induced acute respiratory distress syndrome via activation of mitochondrion-dependent Sirt3/AMPK pathway].
Topics: Acute Lung Injury; AMP-Activated Protein Kinases; Animals; Biphenyl Compounds; Humans; Lignans; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Mitochondria; Signal Transduction; Sirtuin 3 | 2018 |
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation.
Topics: Acute Lung Injury; Animals; Anti-Infective Agents; Biphenyl Compounds; Endotoxemia; Inflammation; Lignans; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Oxidative Stress; Sepsis | 2011 |
Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis.
Topics: Acinar Cells; Acute Disease; Acute Lung Injury; Amylases; Animals; Apoptosis; Biphenyl Compounds; Caspase 3; Disease Models, Animal; Endoplasmic Reticulum; Enzyme Inhibitors; HMGB1 Protein; Interleukin-1beta; Lignans; Lipase; Lung; Male; Mice; Mice, Inbred BALB C; Pancreas; Pancreatitis; Time Factors; Transcription Factor CHOP; Tumor Necrosis Factor-alpha | 2012 |